We are live on !
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter Est. Return
+6.72%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$281M
AUM Growth
+$47.6M
(+20%)
Cap. Flow
+$23.4M
Cap. Flow % of AUM
Cap. Flow %
8.3%
Top 10 Holdings %
Top 10 Hldgs %
45.9%
Holding
164
New
35
Increased
26
Reduced
12
Closed
17
Avg Time Held
Equity + Options
2.4
years
Top 10 Avg Time Held
Equity + Options
2
years
Top 20 Avg Time Held
Equity + Options
1.7
years
Avg Time Held Equity only
2.4
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coliseum Acquisition Corp. Unit
MITAU
|
+$14.7M |
| 2 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
+$6.6M |
| 3 |
FAZE
FaZe Holdings Inc. Common Stock
FAZE
|
+$5.13M |
| 4 |
Twelve Seas Investment Company II Class A Common Stock
TWLV
|
+$4.99M |
| 5 |
GLHA
Glass Houses Acquisition Corp. Class A common stock
GLHA
|
+$4.83M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.9% |
| 2 | Healthcare | 23.27% |
| 3 | Miscellaneous | 14.09% |
| 4 | Materials | 10.3% |
| 5 | Communication Services | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Corteva
CTVA
$8.59B
| $534K | 0.19% |
12,033
| – | – |
2019 Q2
8 quarters
|
|
77
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $503K | 0.18% |
13,150
| – | – |
2014 Q2
28 quarters
|
|
78
W.P. Carey
WPC
$14.8B
| $448K | 0.16% |
6,126
| – | – |
2017 Q3
15 quarters
|
|
79
UP Fintech Holding
TIGR
$728M
| $398K | 0.14% |
13,736
| – | – |
2021 Q1
1 quarter
|
|
80
Microsoft
MSFT
$3.93T
| $379K | 0.13% |
1,400
| – | – |
2013 Q2
32 quarters
|
|
81
Conagra Brands
CAG
$6.91B
| $364K | 0.13% |
10,000
| – | – |
2017 Q3
15 quarters
|
|
82
Globus Medical
GMED
$10.3B
| $359K | 0.13% |
4,631
| – | – |
2019 Q1
9 quarters
|
|
83
Protara Therapeutics
TARA
$137M
| $352K | 0.13% |
36,164
+21,795
| +152% | +$247K |
2020 Q1
5 quarters
|
|
84
DELISTED
Alimera Sciences
ALIM
| $348K | 0.12% |
38,226
-19,882
| -34% | -$195K |
2017 Q3
15 quarters
|
|
|
IBER
85
DELISTED
Ibere Pharmaceuticals
IBER
| $348K | 0.12% |
+36,000
| New | +$350K |
2021 Q2
0 quarters
|
|
86
Meta Platforms (Facebook)
META
$1.81T
| $344K | 0.12% |
990
| – | – |
2021 Q1
1 quarter
|
|
87
CRISPR Therapeutics
CRSP
$4.76B
| $324K | 0.12% |
+2,000
| New | +$243K |
2021 Q2
0 quarters
|
|
88
Jumia Technologies
JMIA
$779M
| $297K | 0.11% |
9,800
+4,100
| +72% | +$124K |
2021 Q1
1 quarter
|
|
89
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $296K | 0.11% |
29,566
| – | – |
2021 Q1
1 quarter
|
|
90
Apple
AAPL
$5.01T
| $288K | 0.1% |
2,100
| – | – |
2013 Q2
32 quarters
|
|
|
QTEKW
91
DELISTED
QualTek Services Inc. Warrant
QTEKW
| $288K | 0.1% |
+25,000
| New | +$27.1K |
2021 Q2
0 quarters
|
|
|
MSACW
92
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
| $256K | 0.09% |
+22,222
| New | +$17.6K |
2021 Q2
0 quarters
|
|
93
FS Bancorp
FSBW
$353M
| $255K | 0.09% |
7,154
| – | – |
2018 Q4
10 quarters
|
|
|
WARR
94
DELISTED
Warrior Technologies Acquisition Company
WARR
| $242K | 0.09% |
+25,000
| New | +$243K |
2021 Q2
0 quarters
|
|
95
Perrigo
PRGO
$2.31B
| $225K | 0.08% |
+4,915
| New | +$218K |
2021 Q2
0 quarters
|
|
|
SIOX
96
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $218K | 0.08% |
80,000
+10,000
| +14% | +$24.9K |
2020 Q4
2 quarters
|
|
|
IBER.WS
97
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
| $207K | 0.07% |
+18,000
| New | +$10.9K |
2021 Q2
0 quarters
|
|
98
Relmada Therapeutics
RLMD
$331M
| $192K | 0.07% |
6,000
+3,000
| +100% | +$104K |
2020 Q2
4 quarters
|
|
99
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $191K | 0.07% |
19
| – | – |
2021 Q1
1 quarter
|
|
100
SouthState Bank Corp
SSB
$9.9B
| $171K | 0.06% |
2,082
| – | – |
2020 Q2
4 quarters
|
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q2 2021 Portfolio in Review
As of Q2 2021, David M. Knott held 164 positions worth $281M, up 20% from $234M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
David M. Knott deployed $23.4M of net new capital in Q2 2021, opening 35 new positions and adding to 26 existing holdings. Its largest new stake was Coliseum Acquisition Corp. Unit: 1,485,000 shares worth $14.7M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 23% a quarter earlier, followed by Healthcare and Miscellaneous.
On the sell side, the largest reduction was Gilead Sciences, an estimated $2.37M trimmed.
- David M. Knott's largest Q2 2021 buy was Coliseum Acquisition Corp. Unit: 1,485,000 shares worth $14.7M.
- David M. Knott added most to Calumet Specialty Products in Q2 2021, an estimated $1.9M increase.
- David M. Knott's biggest Q2 2021 reduction was Gilead Sciences, cutting an estimated $2.37M.
- David M. Knott fully exited African Gold Acquisition Corp Units in Q2 2021, selling an estimated $6.11M.
- David M. Knott's ten largest holdings make up 46% of its $281M portfolio in Q2 2021.
- David M. Knott opened 35 new positions and closed 17 in Q2 2021.
- David M. Knott's portfolio value rose 20% quarter-over-quarter to $281M.
Based on David M. Knott's 13F filing for Q2 2021, filed 13 Aug 2021.